When: January 26 - 28, 2021
DIA's Pharmacovigilance and Risk Management Strategies Conference provides the foundation for strong strategic planning and practical decision-making in your pharmacovigilance programs. Developed by recognized experts from the biopharmaceutical industry and global regulatory agencies, this conference provides the background, context, and opportunities to discuss current challenges and to problem-solve around issues that matter most to professionals working in the field.
This year’s conference will address the current thinking on predicting and assessing risks such as drug-induced liver injury, and the assessment of expectedness of serious adverse reactions during clinical development.
Linguamatics Director of Life Science, Dr. Jane Reed, will be presenting "Using Natural Language Processing (NLP) in Product Safety" on Wednesday, January 27, 2021 – 1:30-3pm EST.